News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

|Videos|April 8, 2022

Improving the Care Continuum

An expert advises how to optimize the care continuum for patients with ASCVD.

Episodes in this series

EP. 1 The Burden of ASCVD and Evidence-Based Guidelines

EP. 1 The Burden of ASCVD and Evidence-Based Guidelines

EP. 2 A Patient’s Post-MI Journey

EP. 2 A Patient’s Post-MI Journey

EP. 3 Improving the Care Continuum

EP. 3 Improving the Care Continuum

EP. 4 Residual Cardiovascular Risk

EP. 4 Residual Cardiovascular Risk

EP. 5 Who is an Ideal Patient for Early Intensive Lipid Lowering?

EP. 5 Who is an Ideal Patient for Early Intensive Lipid Lowering?

EP. 6 Finding the Optimal Statin Dose

EP. 6 Finding the Optimal Statin Dose

EP. 7 Therapy Beyond Statins in the Inpatient Setting

EP. 7 Therapy Beyond Statins in the Inpatient Setting

EP. 8 Using Adjunct Therapies in LDL Management

EP. 8 Using Adjunct Therapies in LDL Management

EP. 9 Ensuring Continuity of Care for the ASCVD Patient

EP. 9 Ensuring Continuity of Care for the ASCVD Patient

EP. 10 Unmet Needs in Lipid Management

EP. 10 Unmet Needs in Lipid Management

EP. 11 Defining “Optimal Care” for ASCVD Within Health Systems

EP. 11 Defining “Optimal Care” for ASCVD Within Health Systems

EP. 12 What Does a Multidisciplinary Team Look Like?

EP. 12 What Does a Multidisciplinary Team Look Like?

EP. 13 The Future of LDL Management for Patients With High-Risk ASCVD

EP. 13 The Future of LDL Management for Patients With High-Risk ASCVD

EP. 14 Enhancing Patient Care Through Guideline Adherence

EP. 14 Enhancing Patient Care Through Guideline Adherence

EP. 15 Improving Access to PCSK9 Inhibitors in the Inpatient Setting

EP. 15 Improving Access to PCSK9 Inhibitors in the Inpatient Setting

EP. 16 Appropriate ASCVD Treatment Outside of Closed Health Systems

EP. 16 Appropriate ASCVD Treatment Outside of Closed Health Systems

EP. 17 Utilizing Quality Metrics in ASCVD

EP. 17 Utilizing Quality Metrics in ASCVD

EP. 18 Improving Patient and Provider Engagement

EP. 18 Improving Patient and Provider Engagement

EP. 19 Treatment Disparities in the Management of ASCVD

EP. 19 Treatment Disparities in the Management of ASCVD

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Cost of health care | Image Credit: Scott Hales - stock.adobe.com

Elective PVI for Claudication Linked to Higher Limb Loss, Costs

ByPearl Steinzor

September 5th 2026

Alynlam | Image credit: Veronique - stock.adobe.com

Vutrisiran Effects Consistent With, Without Tafamidis in ATTR-CM

ByPearl Steinzor

September 4th 2026

Andrew Kuykendall, MD | Image Credit: Moffitt Cancer Center

Rusfertide Approval Aims to Close PV Hematocrit Control Gaps

ByAndrew Kuykendall, MD,Maggie L. Shaw

September 4th 2026

gMG Rescue Therapy Access Varies by Hospital: Richard Nowak, MD, MS

ByHabiba Atta,Richard J. Nowak, MD, MS

September 4th 2026

Keith Bellovich, Do, MBA

CKM Guideline Aims to Break Down Specialty Silos: Keith Bellovich, DO

ByGiuliana Grossi,Keith Bellovich, DO, MBA

September 3rd 2026

Trending on AJMC

FDA Approves Camizestrant for ER+, HER2– mBC With ESR1 Mutations

Vutrisiran Effects Consistent With, Without Tafamidis in ATTR-CM

AI Model Flags Colorectal Cancer on Routine Noncontrast CT Scans

The Next Frontier in Hepatitis B Functional and Virologic Cure

Cardiac Risks of COVID-19 Vaccine vs Infection: Eman Toraih, MD, PhD